ӳ��ý

Publications

Long COVID clinical evaluation, research and impact on society: a global expert consensus.

Ewing AG, Joffe D, Blitshteyn S, et al. Long COVID clinical evaluation, research and impact on society: a global expert consensus. Annals of clinical microbiology and antimicrobials. 2025;24(1):27. doi:10.1186/s12941-025-00793-9

Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Incidence of Venous Thromboembolism in Older Adults.

Saadatagah S, Kim RB, Sukumar S, et al. Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Incidence of Venous Thromboembolism in Older Adults. Journal of thrombosis and haemostasis : JTH. 2025. doi:10.1016/j.jtha.2025.03.042

Unified molecular approach for spatial epigenome, transcriptome, and cell lineages.

Huang YH, Belk JA, Zhang R, et al. Unified molecular approach for spatial epigenome, transcriptome, and cell lineages. Proceedings of the National Academy of Sciences of the United States of America. 2025;122(16):e2424070122. doi:10.1073/pnas.2424070122

Proteomic-based stemness score measures oncogenic dedifferentiation and enables the identification of druggable targets.

Kołodziejczak-Guglas I, Simões RLS, Santos E de S, et al. Proteomic-based stemness score measures oncogenic dedifferentiation and enables the identification of druggable targets. Cell genomics. 2025:100851. doi:10.1016/j.xgen.2025.100851

Association between plausible genetic factors and weight loss from GLP1-RA and bariatric surgery.

German J, Cordioli M, Tozzo V, et al. Association between plausible genetic factors and weight loss from GLP1-RA and bariatric surgery. Nature medicine. 2025. doi:10.1038/s41591-025-03645-3

Systemic inflammation impairs myelopoiesis and interferon type I responses in humans.

Keramati F, Leijte GP, Bruse N, et al. Systemic inflammation impairs myelopoiesis and interferon type I responses in humans. Nature immunology. 2025. doi:10.1038/s41590-025-02136-4

Mitochondrial DNA variant detection in over 6,500 rare disease families by the systematic analysis of exome and genome sequencing data resolves undiagnosed cases.

Stenton SL, Laricchia K, Lake NJ, et al. Mitochondrial DNA variant detection in over 6,500 rare disease families by the systematic analysis of exome and genome sequencing data resolves undiagnosed cases. HGG advances. 2025:100441. doi:10.1016/j.xhgg.2025.100441

Trends in Risk Factor Management Among Stroke Survivors in a Representative US Population.

Tack RWP, Senff JR, Tan BY, et al. Trends in Risk Factor Management Among Stroke Survivors in a Representative US Population. American journal of lifestyle medicine. 2025:15598276251333369. doi:10.1177/15598276251333369

variants contribute to FSGS susceptibility across multiple populations.

Skitchenko R, Modrusan Z, Loboda A, et al. variants contribute to FSGS susceptibility across multiple populations. iScience. 2025;28(4):112234. doi:10.1016/j.isci.2025.112234

Rewriting regulatory DNA to dissect and reprogram gene expression.

Martyn GE, Montgomery MT, Jones H, et al. Rewriting regulatory DNA to dissect and reprogram gene expression. Cell. 2025. doi:10.1016/j.cell.2025.03.034